For: | Tsuchikawa T, Takeuchi S, Nakamura T, Shichinohe T, Hirano S. Clinical impact of chemotherapy to improve tumor microenvironment of pancreatic cancer. World J Gastrointest Oncol 2016; 8(11): 786-792 [PMID: 27895816 DOI: 10.4251/wjgo.v8.i11.786] |
---|---|
URL: | https://www.wjgnet.com/1948-5204/full/v8/i11/786.htm |
Number | Citing Articles |
1 |
Zhenfeng Shi, Jifang Liu, Lei Tian, Jingyi Li, Yue Gao, Yue Xing, Wenjing Yan, Chenyu Hua, Xiaolin Xie, Chang Liu, Chengyuan Liang. Insights into stimuli-responsive diselenide bonds utilized in drug delivery systems for cancer therapy. Biomedicine & Pharmacotherapy 2022; 155: 113707 doi: 10.1016/j.biopha.2022.113707
|
2 |
Reetu Mukherji, Dipanjan Debnath, Marion L. Hartley, Marcus S. Noel. The Role of Immunotherapy in Pancreatic Cancer. Current Oncology 2022; 29(10): 6864 doi: 10.3390/curroncol29100541
|
3 |
Yongping Zhou, Qian Wei, Junsheng Fan, Sijin Cheng, Wenzhou Ding, Zhiyuan Hua. Prognostic role of the neutrophil-to-lymphocyte ratio in pancreatic cancer: A meta-analysis containing 8252 patients. Clinica Chimica Acta 2018; 479: 181 doi: 10.1016/j.cca.2018.01.024
|
4 |
Carl J. DeSelm, Zachary E. Tano, Anna M. Varghese, Prasad S. Adusumilli. CAR T‐cell therapy for pancreatic cancer. Journal of Surgical Oncology 2017; 116(1): 63 doi: 10.1002/jso.24627
|
5 |
Abhishek D. Garg, Sanket More, Nicole Rufo, Odeta Mece, Maria Livia Sassano, Patrizia Agostinis, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi. Trial watch: Immunogenic cell death induction by anticancer chemotherapeutics. OncoImmunology 2017; 6(12): e1386829 doi: 10.1080/2162402X.2017.1386829
|
6 |
Andreas Henriksen, Anne Dyhl-Polk, Inna Chen, Dorte Nielsen. Checkpoint inhibitors in pancreatic cancer. Cancer Treatment Reviews 2019; 78: 17 doi: 10.1016/j.ctrv.2019.06.005
|
7 |
Chen Liu, He Cheng, Guopei Luo, Yu Lu, Kaizhou Jin, Meng Guo, Quanxing Ni, Xianjun Yu. Circulating regulatory T cell subsets predict overall survival of patients with unresectable pancreatic cancer. International Journal of Oncology 2017; 51(2): 686 doi: 10.3892/ijo.2017.4032
|
8 |
L.C. Cutmore, N.F. Brown, D. Raj, S. Chauduri, P. Wang, J. Maher, Y. Wang, N.R. Lemoine, J.F. Marshall. Pancreatic Cancer UK Grand Challenge: Developments and challenges for effective CAR T cell therapy for pancreatic ductal adenocarcinoma. Pancreatology 2020; 20(3): 394 doi: 10.1016/j.pan.2020.02.006
|
9 |
Xinming Yun, Qin Zhang, Yulai Fang, Changjun Lv, Qingyong Chen, Yuyao Chu, Yanrong Zhu, Zhifeng Wei, Yufeng Xia, Yue Dai. Madecassic acid alleviates colitis-associated colorectal cancer by blocking the recruitment of myeloid-derived suppressor cells via the inhibition of IL-17 expression in γδT17 cells. Biochemical Pharmacology 2022; 202: 115138 doi: 10.1016/j.bcp.2022.115138
|
10 |
Tianqi Su, Bo Yang, Tianren Gao, Tongjun Liu, Jiannan Li. Polymer nanoparticle-assisted chemotherapy of pancreatic cancer. Therapeutic Advances in Medical Oncology 2020; 12 doi: 10.1177/1758835920915978
|
11 |
Skaiste Tulyte, Dainius Characiejus, Reda Matuzeviciene, Ausra Janiulioniene, Mantas Radzevicius, Elena Jasiunaite, Tadas Zvirblis, Audrius Sileikis. Prognostic value of circulating T-lymphocyte subsets in advanced pancreatic cancer patients treated with mFOLFIRINOX or gemcitabine. International Immunopharmacology 2023; 115: 109722 doi: 10.1016/j.intimp.2023.109722
|